Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Total Liabilities: 2017-2019

Historic Total Liabilities for Astria Therapeutics (ATXS) over the last 3 years, with Sep 2019 value amounting to $5.6 million.

  • Astria Therapeutics' Total Liabilities rose 33.04% to $5.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $5.6 million, marking a year-over-year increase of 33.04%. This contributed to the annual value of $4.2 million for FY2018, which is 30.76% down from last year.
  • Astria Therapeutics' Total Liabilities amounted to $5.6 million in Q3 2019, which was up 7.60% from $5.2 million recorded in Q2 2019.
  • In the past 5 years, Astria Therapeutics' Total Liabilities registered a high of $9.5 million during Q1 2017, and its lowest value of $4.2 million during Q3 2018.
  • For the 3-year period, Astria Therapeutics' Total Liabilities averaged around $6.1 million, with its median value being $5.4 million (2018).
  • As far as peak fluctuations go, Astria Therapeutics' Total Liabilities crashed by 45.66% in 2018, and later surged by 33.04% in 2019.
  • Over the past 3 years, Astria Therapeutics' Total Liabilities (Quarterly) stood at $6.1 million in 2017, then plummeted by 30.76% to $4.2 million in 2018, then skyrocketed by 33.04% to $5.6 million in 2019.
  • Its Total Liabilities was $5.6 million in Q3 2019, compared to $5.2 million in Q2 2019 and $4.6 million in Q1 2019.